{"id":251443,"date":"2012-02-16T10:16:00","date_gmt":"2012-02-16T10:16:00","guid":{"rendered":"http:\/\/www.eugenesis.com\/fitch-insurance-longevity-product-raises-questions-and-concerns\/"},"modified":"2012-02-16T10:16:00","modified_gmt":"2012-02-16T10:16:00","slug":"fitch-insurance-longevity-product-raises-questions-and-concerns","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/longevity\/fitch-insurance-longevity-product-raises-questions-and-concerns.php","title":{"rendered":"Fitch: Insurance Longevity Product Raises Questions and Concerns"},"content":{"rendered":"<p><p>    NEW YORK &amp; CHICAGO--(BUSINESS WIRE)--  <\/p>\n<p>    Fitch notes the latest product offering aimed at the longevity    risk protection market, the contingent annuity (CA), is    generating controversy. From a ratings perspective, we are    concerned with the ultimate risk profile of any CA products,    pricing adequacy, questions of transparency, and how the    product will be reserved for considering the level of capital    required under regulatory capital ratios.  <\/p>\n<p>    The market for longevity risk protection is enormous and    growing rapidly, as underscored by an ongoing shift toward    defined contribution pension plans and baby boomers reaching    retirement age.  <\/p>\n<p>    To date, U.S. life insurers have been actively selling variable    annuities and other lifetime income annuities that protect    against the risk of outliving one&#039;s assets. The CA product    structures that have been proposed would offer similar lifetime    income benefit guarantees but would not require the    policyholder to transfer the assets to the insurance company.    We are aware of only a handful of U.S. life insurers that have    actually sold a CA type product; however, a large number of    insurers are looking to potentially enter this market given    recent policy statements from the Treasury and Labor    departments encouraging lifetime annuities.  <\/p>\n<p>    We share key concerns voiced by U.S. life insurance companies,    regulators, and trade group, including the potential for    mispricing that could lead to significant financial problems    for the life insurance industry down the road. Due to    investment guarantees embedded in variable annuity products,    the industry suffered material financial losses in the    2008-2009 financial crisis. We also share concerns that the CA    product offering could cannibalize sales of existing annuity    products and will not necessarily increase market share.  <\/p>\n<p>    We do not portend any rating impact over the near term    associated with the development of CA offerings and note that    there has been very little business written in the new product    to date. Over the near term, we will be actively monitoring    further developments related to the CA market, including    forthcoming recommendations from the subgroup recently formed    by the National Association of Insurance Commissioners (NAIC)    to examine this market, and will discuss potential reserve and    capital requirements.  <\/p>\n<p>    Additional information is available on     <a href=\"http:\/\/www.fitchratings.com\" rel=\"nofollow\">http:\/\/www.fitchratings.com<\/a>  <\/p>\n<p>    The above article originally appeared as a post on the Fitch    Wire credit market commentary page. The original article, which    may include hyperlinks to companies and current ratings, can be    accessed at     <a href=\"http:\/\/www.fitchratings.com\" rel=\"nofollow\">http:\/\/www.fitchratings.com<\/a>. All opinions expressed are those of    Fitch Ratings.  <\/p>\n<p>    ALL FITCH CREDIT RATINGS ARE SUBJECT TO CERTAIN LIMITATIONS AND    DISCLAIMERS. PLEASE READ THESE LIMITATIONS AND DISCLAIMERS BY    FOLLOWING THIS LINK:     <a href=\"http:\/\/FITCHRATINGS.COM\/UNDERSTANDINGCREDITRATINGS\" rel=\"nofollow\">http:\/\/FITCHRATINGS.COM\/UNDERSTANDINGCREDITRATINGS<\/a>. IN    ADDITION, RATING DEFINITIONS AND THE TERMS OF USE OF SUCH    RATINGS ARE AVAILABLE ON THE AGENCY&#039;S PUBLIC WEBSITE &#039;WWW.FITCHRATINGS.COM&#039;.    PUBLISHED RATINGS, CRITERIA AND METHODOLOGIES ARE AVAILABLE    FROM THIS SITE AT ALL TIMES. FITCH&#039;S CODE OF CONDUCT,    CONFIDENTIALITY, CONFLICTS OF INTEREST, AFFILIATE FIREWALL,    COMPLIANCE AND OTHER RELEVANT POLICIES AND PROCEDURES ARE ALSO    AVAILABLE FROM THE &#039;CODE OF CONDUCT&#039; SECTION OF THIS SITE.  <\/p>\n<\/p>\n<p>The rest is here:<br \/>\n<a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/fitch-insurance-longevity-product-raises-190900094.html\" title=\"Fitch: Insurance Longevity Product Raises Questions and Concerns\">Fitch: Insurance Longevity Product Raises Questions and Concerns<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> NEW YORK &amp; CHICAGO--(BUSINESS WIRE)-- Fitch notes the latest product offering aimed at the longevity risk protection market, the contingent annuity (CA), is generating controversy. From a ratings perspective, we are concerned with the ultimate risk profile of any CA products, pricing adequacy, questions of transparency, and how the product will be reserved for considering the level of capital required under regulatory capital ratios. The market for longevity risk protection is enormous and growing rapidly, as underscored by an ongoing shift toward defined contribution pension plans and baby boomers reaching retirement age <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/longevity\/fitch-insurance-longevity-product-raises-questions-and-concerns.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577495],"tags":[],"class_list":["post-251443","post","type-post","status-publish","format-standard","hentry","category-longevity"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/251443"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=251443"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/251443\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=251443"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=251443"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=251443"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}